Simvastatin Use in Patients with Type 2 Diabetes Mellitus: The Effects on Oxidative Stress

Najah R Hadi1, Mohammad A Abdelhussein2, Ammar R M Rudha1

  • 1Department of Pharmacology, Kufa University, Najaf, Iraq.

Oman Medical Journal
|September 15, 2015
PubMed
Abstract

Insights

Simvastatin treatment significantly reduced oxidative stress and improved serum lipids in patients with type 2 diabetes mellitus (T2DM). This study demonstrates simvastatin

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • Type 2 diabetes mellitus (T2DM) is linked to atherosclerosis, oxidative stress, and dyslipidemia.
  • Oxidative control disturbances and dyslipidemia are key factors in T2DM complications.

Purpose of the Study:

  • To evaluate the benefits of simvastatin in T2DM patients.
  • To assess simvastatin's impact on serum lipids and oxidative damage.

Main Methods:

  • A 12-week randomized controlled trial involving 56 T2DM patients with dyslipidemia.
  • Participants received either simvastatin (20mg/day) or a placebo, alongside glibenclamide.
  • Measurements included blood pressure, pulse rate, serum lipids, and oxidative stress markers.

Main Results:

  • Simvastatin significantly reduced erythrocyte glutathione and malondialdehyde (p<0.001).
  • Improved serum lipid profiles were observed in the simvastatin group.
  • These findings indicate reduced lipid peroxidation and oxidative stress.

Conclusions:

  • Simvastatin demonstrates a beneficial role in managing oxidative stress in T2DM.
  • The drug improves serum lipids and mitigates lipid peroxidation.
  • This highlights simvastatin's potential in T2DM management.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
632
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
957
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K